PortalPublikationenEngineering Cardiovascular Regeneration

Engineering Cardiovascular Regeneration

Standard

Engineering Cardiovascular Regeneration. / Vollert, Ingra; Eder, Alexandra; Hansen, Arne; Eschenhagen, Thomas.

in: CURR STEM CELL REP, Jahrgang 1, Nr. 2, 03.04.2015, S. 67-78.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Vollert, I, Eder, A, Hansen, A & Eschenhagen, T 2015, 'Engineering Cardiovascular Regeneration', CURR STEM CELL REP, Jg. 1, Nr. 2, S. 67-78. https://doi.org/10.1007/s40778-015-0010-8

APA

Vollert, I., Eder, A., Hansen, A., & Eschenhagen, T. (2015). Engineering Cardiovascular Regeneration. CURR STEM CELL REP, 1(2), 67-78. https://doi.org/10.1007/s40778-015-0010-8

Vancouver

Vollert I, Eder A, Hansen A, Eschenhagen T. Engineering Cardiovascular Regeneration. CURR STEM CELL REP. 2015 Apr 3;1(2):67-78. https://doi.org/10.1007/s40778-015-0010-8

Bibtex

@article{3c8e56b4c7c840bf9cd6cb0cc75ca053,
title = "Engineering Cardiovascular Regeneration",
abstract = "The human heart has very limited regenerative capacity, making the loss of heart muscle tissue during myocardial infarction essentially irreversible. Regenerative medicine aims at promoting the formation of new functional heart muscle in an injured heart, either by stimulating myocyte proliferation, formation of myocytes from preexisting stem cells, direct reprogramming of fibroblasts into myocytes, or adding new muscle tissue from exogenous stem cell sources. Recent advances in stem cell research make these goals more realistic. This review provides a short overview about different approaches for cardiovascular regeneration, stem cell sources, and modes of application, focusing on current cardiac tissue engineering techniques and their way towards clinical application",
author = "Ingra Vollert and Alexandra Eder and Arne Hansen and Thomas Eschenhagen",
year = "2015",
month = apr,
day = "3",
doi = "10.1007/s40778-015-0010-8",
language = "English",
volume = "1",
pages = "67--78",
journal = "CURR STEM CELL REP",
issn = "2198-7866",
publisher = "Springer International Publishing",
number = "2",

}

RIS

TY - JOUR

T1 - Engineering Cardiovascular Regeneration

AU - Vollert, Ingra

AU - Eder, Alexandra

AU - Hansen, Arne

AU - Eschenhagen, Thomas

PY - 2015/4/3

Y1 - 2015/4/3

N2 - The human heart has very limited regenerative capacity, making the loss of heart muscle tissue during myocardial infarction essentially irreversible. Regenerative medicine aims at promoting the formation of new functional heart muscle in an injured heart, either by stimulating myocyte proliferation, formation of myocytes from preexisting stem cells, direct reprogramming of fibroblasts into myocytes, or adding new muscle tissue from exogenous stem cell sources. Recent advances in stem cell research make these goals more realistic. This review provides a short overview about different approaches for cardiovascular regeneration, stem cell sources, and modes of application, focusing on current cardiac tissue engineering techniques and their way towards clinical application

AB - The human heart has very limited regenerative capacity, making the loss of heart muscle tissue during myocardial infarction essentially irreversible. Regenerative medicine aims at promoting the formation of new functional heart muscle in an injured heart, either by stimulating myocyte proliferation, formation of myocytes from preexisting stem cells, direct reprogramming of fibroblasts into myocytes, or adding new muscle tissue from exogenous stem cell sources. Recent advances in stem cell research make these goals more realistic. This review provides a short overview about different approaches for cardiovascular regeneration, stem cell sources, and modes of application, focusing on current cardiac tissue engineering techniques and their way towards clinical application

U2 - 10.1007/s40778-015-0010-8

DO - 10.1007/s40778-015-0010-8

M3 - SCORING: Journal article

VL - 1

SP - 67

EP - 78

JO - CURR STEM CELL REP

JF - CURR STEM CELL REP

SN - 2198-7866

IS - 2

ER -